سعر سيبروتك اكس ال 1000 مجم 5 أقراص ممتدة المفعول مغلفة 2026

Ciprofloxacin 1000 mg Extended-release film-coated tablet (Ciprotak xl 1000 mg extended release 5 f.c.tab., NAPCO > Novell Pharma, Egypt); Box of 5 extended-release film-coated tablets.

• Uncomplicated urinary tract infections (acute cystitis) due to susceptible organisms — US ciprofloxacin ER labeling (once daily).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Complicated urinary tract infections or acute uncomplicated pyelonephritis due to susceptible organisms — US ciprofloxacin 1000 mg ER once daily regimens (as labeled).Population: AdultsDailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to ciprofloxacin, any member of the quinolone class or any product component.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Concomitant administration with tizanidine.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Boxed warning: fluoroquinolones have been associated with disabling and potentially irreversible serious adverse reactions occurring together, including tendinitis and tendon rupture, peripheral neuropathy and central nervous system effects; discontinue immediately and avoid fluoroquinolones in patients who experience them.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Boxed warning: may exacerbate muscle weakness in patients with myasthenia gravis; avoid in patients with a known history of myasthenia gravis.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Boxed warning: because of these risks, reserve for patients with no alternative treatment options for acute exacerbation of chronic bronchitis, acute uncomplicated cystitis and acute sinusitis.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Prolonged experience with ciprofloxacin in pregnant women over several decades (case reports, case-control and observational studies) has not identified any drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Ciprofloxacin is present in human milk; because of potential serious adverse reactions in breastfed infants (including arthropathy in juvenile animals), a woman may pump and discard milk during treatment and for 2 more days after the last dose, or not breastfeed during that time.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ciprofloxacin: Bactericidal fluoroquinolone that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, blocking DNA replication.